ORMP
Oramed Pharmaceuticals IncNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$163.00M
P/E Ratio
2.69
EPS
$1.50
Beta
1.25
52W High
$4.22
52W Low
$1.85
50-Day MA
$3.51
200-Day MA
$2.83
Dividend Yield
0.00%
Profit Margin
3202.00%
Forward P/E
—
PEG Ratio
0.00
About Oramed Pharmaceuticals Inc
Oramed Pharmaceuticals Inc. is dedicated to the research and development of pharmaceutical solutions for the treatment of diabetes and for the use of orally ingestible capsules or pills for the administration of polypeptides. The company is headquartered in New York, New York.
Fundamentals
| Revenue (TTM) | $2.00M |
| Gross Profit (TTM) | 13,000 |
| EBITDA | $-14.97M |
| Operating Margin | -754.00% |
| Return on Equity | 37.10% |
| Return on Assets | -4.88% |
| Revenue/Share (TTM) | $0.05 |
| Book Value | $5.09 |
| Price-to-Book | 0.83 |
| Price-to-Sales (TTM) | 81.50 |
| EV/Revenue | 20.58 |
| EV/EBITDA | 0.55 |
| Quarterly Earnings Growth (YoY) | 40.90% |
| Quarterly Revenue Growth (YoY) | -100.00% |
| Shares Outstanding | $40.45M |
| Float | $30.21M |
| % Insiders | 18.05% |
| % Institutions | 27.79% |
Historical Volatility
HV 10-Day
37.73%
HV 20-Day
37.45%
HV 30-Day
41.14%
HV 60-Day
50.05%
HV Rank
29.4%
Volatility is currently contracting
Data last updated: 4/29/2026